PMID: 20118503Feb 2, 2010Paper

Fetal echocardiography in Iceland 2003-2007; indications and outcomes

Læknablađiđ
Sigurveig ThórisdóttirGunnlaugur Sigfusson

Abstract

The aim of the study was to evaluate the indications and outcomes of fetal echo (FE) and determine which indication has the highest detection rate for congenital heart disease (CHD). The referral indications and results of FE performed in Iceland during 2003-2007 were reviewed. Information regarding gestational age at diagnosis, nuchal translucency, pregnancy outcome, autopsy results and postnatal diagnosis were obtained from medical records. During the five year period 1187 FE were performed. Structural heart defect was diagnosed in 73 fetuses. The most common referral indication was family history of CHD (631;53.2%) which led to diagnosis of 18 heart defects prenatally (2.9%). The second most common referral indication was increased nuchal translucency (159) and abnormal cardiac findings were present in 16 cases (10.1%). A total of 30 women were referred for FE because of abnormal four chamber view (AFCV) which resulted in the diagnosis of 22 (73.3%) major heart defects, either incompatible with life or requiring immediate intervention after birth. Other indications led mostly to the diagnoses of minor defects. AFCV is the most important predictor for diagnosis of structural heart defects. 2,5% were referred for FE due to AFC...Continue Reading

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Related Papers

Scandinavian Journal of Primary Health Care
Emil L SigurdssonGudmundur Thorgeirsson
Practical Neurology
Finnbogi Jakobsson, Elías Olafsson
Department of State Publication. Background Notes Series
United States. Department of State. Bureau of Public Affairs
© 2021 Meta ULC. All rights reserved